PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 42 filers reported holding PEAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $12,813,679 | -42.2% | 10,859,050 | 0.0% | 23.91% | +7.0% |
| Q3 2022 | $22,152,000 | +32.5% | 10,859,050 | 0.0% | 22.34% | +20.3% |
| Q2 2022 | $16,723,000 | -69.5% | 10,859,050 | 0.0% | 18.57% | -58.3% |
| Q1 2022 | $54,838,000 | -18.5% | 10,859,050 | 0.0% | 44.55% | +14.9% |
| Q4 2021 | $67,326,000 | – | 10,859,050 | – | 38.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arboretum Ventures, Inc. | 10,859,050 | $16,723,000 | 18.57% |
| 5AM Venture Management, LLC | 18,631,771 | $28,693,000 | 7.10% |
| Palantir Technologies Inc. | 1,000,000 | $1,540,000 | 1.58% |
| TB Alternative Assets Ltd. | 2,071,865 | $3,191,000 | 1.56% |
| SB Global Advisers Ltd | 12,100,078 | $18,634,000 | 0.88% |
| EDBI Pte Ltd | 427,070 | $658,000 | 0.61% |
| Temasek Holdings (Private) Ltd | 26,803,573 | $41,277,502 | 0.23% |
| Sarissa Capital Management LP | 500,356 | $771,000 | 0.08% |
| Perceptive Advisors | 900,548 | $1,386,000 | 0.04% |
| Ergoteles LLC | 72,098 | $111,000 | 0.00% |